Research Comparison Tool

Compare PeptidesSide-by-Side

Make informed decisions with research-backed comparisons. Evaluate mechanisms, research quality, safety profiles, and practical considerations.

Research-Focused
Safety Profiles
Side-by-Side Analysis

Popular Comparisons

Click to load a pre-built comparison or explore a detailed breakdown

Build Your Comparison

Select 2-3 peptides to compare

VS
← Scroll horizontally to compare →
Feature
Semaglutide
Ozempic/Wegovy/Rybelsus
Tirzepatide
Mounjaro/Zepbound
Status
FDA Approved
FDA Approved
Category
Weight Loss
Weight Loss
Mechanism
Mimics GLP-1, a hormone that tells your brain you're full, slows digestion, and regulates blood sugar.
Activates TWO hunger receptors (GLP-1 and GIP) for a more powerful appetite-suppressing effect.
Key Benefits
  • 15-20% body weight loss in clinical trials
  • Reduced appetite and 'food noise'
  • Improved blood sugar control
  • Cardiovascular benefits
  • 20-25% body weight loss (best in class)
  • Superior to semaglutide in trials
  • Significant blood sugar improvements
  • Better tolerated by some
Dosing
Weekly
Weekly
Delivery
Subcutaneous injectionOral
Oral option
Subcutaneous injection
Cost
$$$
Brand-name Ozempic/Wegovy typically ranges $900-1,500/month without insurance. Compounded versions, where legally available, may range $150-400/month. Insurance coverage varies significantly.
$$$$
Mounjaro/Zepbound typically costs $1,000-1,200/month without insurance. Manufacturer coupons may reduce costs for eligible patients. Compounded versions availability varies by region.
Side Effects
Moderate-High
Low
Common Issues
  • Nausea (Very common (40-50%))
  • Vomiting (Common (25%))
  • Diarrhea (Common (20%))
  • Nausea (Common (30%))
  • Diarrhea (Common (20%))
  • Vomiting (Common (15%))
Research
Extensive
Extensive
FDA Approved
Yes
Yes
Human Trials
Yes
Yes
Best For
BMI ≥30 (obesity)
Those wanting maximum weight loss
Key Advantage
The King of Weight Loss Peptides
The Dual Agonist That Beats Ozempic
Main Drawback
Family history of medullary thyroid cancer
Medullary thyroid cancer history

Research & Educational Purposes Only

This comparison tool is provided for informational and educational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. Peptide research is rapidly evolving, and not all compounds have FDA approval or extensive human clinical data. Always consult with a qualified healthcare provider before considering any peptide protocol. Individual results may vary.

Ready to Learn More?

Explore our comprehensive peptide guides and research summaries to deepen your understanding.